483
Auro PR IncFDA 483 - Auro PR Inc - March 15, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Mylan LLC in Caguas, PR, a drug manufacturer, was cited with four observations during an FDA inspection. The inspection revealed deficiencies in the visual examination of received components, the qualification and calibration of dissolution testing instruments, and the cleaning and maintenance procedures for equipment and utensils. These issues indicate a lack of adequate controls to ensure product quality and integrity.
Open in Dashboard
ID · e251f642-af25-442e-aa4f-6709f8740d8b